BIODESIX, INC. Impairment of Intangible Assets, Finite-lived
BIODESIX, INC. (BDSX) reported Impairment of Intangible Assets, Finite-lived of $12.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2026-08-05
- BIODESIX, INC. impairment of intangible assets, finite-lived for the quarter ending 2026-06-30 was $12.00K, a 53.85% decline year-over-year.
- BIODESIX, INC. impairment of intangible assets, finite-lived for the quarter ending 2026-03-31 was $5.00K, a 93.15% decline year-over-year.
- BIODESIX, INC. impairment of intangible assets, finite-lived for the quarter ending 2025-12-31 was $1.00K, a 99.03% decline year-over-year.
- BIODESIX, INC. impairment of intangible assets, finite-lived for the quarter ending 2025-09-30 was $7.00K.
- BIODESIX, INC. impairment of intangible assets, finite-lived for fiscal 2025 was $107.00K, a 55.04% decline from fiscal 2024.
- BIODESIX, INC. impairment of intangible assets, finite-lived for fiscal 2024 was $238.00K, a 440.91% increase from fiscal 2023.
- BIODESIX, INC. impairment of intangible assets, finite-lived for fiscal 2023 was $44.00K, a 45.68% decline from fiscal 2022.
- BIODESIX, INC. impairment of intangible assets, finite-lived for fiscal 2022 was $81.00K.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 6 month | Impairment of Intangible Assets, Finite-lived 9 month | Impairment of Intangible Assets, Finite-lived 12 month |
|---|---|---|---|---|
| 2026-06-30 | $12.00K 10-Q · filed 2026-08-05 | $17.00K 10-Q · filed 2026-08-05 | $18.00K derived: sum of 3 quarters · filed 2026-08-05 | $25.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $5.00K 10-Q · filed 2026-05-04 | $6.00K derived: sum of 2 quarters · filed 2026-05-04 | $13.00K derived: sum of 3 quarters · filed 2026-05-04 | $39.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.00K derived: sum of 2 quarters · filed 2026-02-26 | $34.00K derived: sum of 3 quarters · filed 2026-08-05 | $107.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $7.00K 10-Q · filed 2025-11-03 | $33.00K derived: sum of 2 quarters · filed 2026-08-05 | $106.00K 10-Q · filed 2025-11-03 | $209.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $26.00K 10-Q · filed 2026-08-05 | $99.00K 10-Q · filed 2026-08-05 | $202.00K derived: sum of 3 quarters · filed 2026-08-05 | $202.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $73.00K 10-Q · filed 2026-05-04 | $176.00K derived: sum of 2 quarters · filed 2026-05-04 | $176.00K derived: sum of 3 quarters · filed 2026-05-04 | $243.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $103.00K derived: sum of 2 quarters · filed 2026-02-26 | $170.00K derived: sum of 3 quarters · filed 2026-02-26 | $238.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $67.00K derived: sum of 2 quarters · filed 2025-11-03 | $135.00K 10-Q · filed 2025-11-03 | $159.00K derived: sum of 4 quarters · filed 2025-11-03 |
| 2024-06-30 | $67.00K 10-Q · filed 2025-08-07 | $135.00K 10-Q · filed 2025-08-07 | $159.00K derived: sum of 3 quarters · filed 2025-08-07 | $159.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $68.00K 10-Q · filed 2025-05-13 | $92.00K derived: sum of 2 quarters · filed 2025-05-13 | $92.00K derived: sum of 3 quarters · filed 2025-05-13 | $92.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $24.00K derived: sum of 2 quarters · filed 2025-03-03 | $24.00K derived: sum of 3 quarters · filed 2025-03-03 | $44.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $0.00 derived: sum of 2 quarters · filed 2024-11-01 | $20.00K 10-Q · filed 2024-11-01 | $20.00K derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $20.00K 10-Q · filed 2024-08-07 | $20.00K derived: sum of 3 quarters · filed 2024-08-07 | $20.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $20.00K 10-Q · filed 2024-05-08 | $20.00K derived: sum of 2 quarters · filed 2024-05-08 | $20.00K derived: sum of 3 quarters · filed 2024-05-08 | $20.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $0.00 derived: sum of 2 quarters · filed 2024-03-01 | $0.00 derived: sum of 3 quarters · filed 2024-03-01 | $81.00K 10-K · filed 2024-03-01 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $81.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $81.00K 10-Q · filed 2023-08-07 | ||
| 2022-03-31 | $81.00K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |